Vaccine Price Updates for 2020

Most vaccines have new pricing in 2020.  Here is a summary of the effective dates for all of CPP’s vendor partners:

  • Merck – effective 10/31/2019
  • Sanofi Pasteur – effective 1/1/2020
  • Pfizer – effective 2/27/2020

Pfizer has announced updated pricing on Trumenba (and Prevnar 13) that went into effect January 1, 2020. There will be a discount period when members can place orders for these vaccines at the pre-increase price until February 26, 2020 (with delivery no later than February 28, 2020). If you would like electronic or hard copies of the updated pricing sheet for Trumenba, please contact the CPP office.

In addition, the CDC has updated its Vaccine Price List for 2020. Prices are current as of January 1, 2020. To find out more and access the list, visit https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html?deliveryName=USCDC_11_19-DM15960

Managing a financially sustainable vaccine program is key to providing the most value to your practice and your patients.  This would include checking your invoices to make sure you’re being charged correctly, checking your billing to make sure your billing rates are adjusted to account for the price changes and checking your insurance payments to make sure they have adjusted accordingly.  CPP offers several price change management resources that are posted on the CPP Resources Webpage to help members manage through vaccine price changes. 

Please contact the CPP office at 614-722-2145 with questions.

2020-2021 Flu Vaccine Pricing & Pre-Book Details

For the upcoming 2020-2021 flu season, CPP members will have two opportunities to save on influenza vaccines:

SANOFI PASTEUR:  CPP members who confirm their flu vaccine reservation on VaccineShoppe.com by the March 31, 2020 deadline will receive the discounted member pricing, delivery commitments and returns allowance.  Please also note that CPP members can now earn an additional 1% rebate from CPP on all Sanofi Pasteur flu vaccine purchases!  To receive these benefits, make sure your Sanofi Pasteur account is linked to the CPP member pricing and confirm your reservation through www.VaccineShoppe.com by the deadline.

ASTRAZENECA:   Members who wish to pre-book FluMist doses will have an opportunity to purchase them at a discount, receive a returns allowance and a supply commitment.  To receive these benefits, confirm that the DEA # for your practice is linked to CPP by submitting a declaration form and pre-book your FluMist doses through your preferred authorized distributor by January 31, 2020 (Early Pre-Book for a larger discount) or March 31, 2020 (Standard Pre-Book).  Declaration forms can be obtained by contacting the CPP office.

For pricing other details, please don’t hesitate to contact the CPP office at 614-722-2145 or cpp@nationwidechildrens.org.

Updated Vaccine Information Statements

Did you know that many Vaccine Information Statements were updated recently? This list below provides the current dates of VISs:

If your VISs are not current, these links will lead you to the current statements:

https://www.cdc.gov/vaccines/hcp/vis/index.html Is this CDCs main hub for Vaccine Information Statements. Find instructions for use, FAQs, and current statements here.

https://www.immunize.org/vis/ Provides quick links to all current VISs and access to multiple languages.

Creating a Culture of Immunization: Resources for Your Practice

All staff in a pediatric practice, including non-clinical staff, play an important role in supporting parents in their immunization decisions. Creating a culture of immunization in your office helps promote complete and timely immunizations. To that end, the CDC and Sanofi Pasteur have produced helpful resources to aid in building a pro-vaccination culture.

The CDC has created presentation available for download called “10 Ways to Create a Culture of Immunization Within Our Pediatric Practice.” The presentation is editable and designed to be customized by each medical practice. The objectives of the presentation are to enable office staff to

  • Understand why practices need a culture of immunization
  • Cite the practice’s current immunization coverage rates
  • Describe how all office staff play a part in creating a culture of immunization
  • Describe several ways to create a culture of immunization

The presentation is easy to customize and contains notes to help guide the discussion.

Another useful resource is the handout “Developing an Immunization Culture in Your Office” by Sanofi Pasteur. This handout breaks down broad ideas concerning immunization culture into succinct, actionable bullet points. It instructs staff to

  • Educate and Motivate Your Staff to Become Vaccine Advocates
  • Capture Every Opportunity to Immunize
  • Prioritize parental education and communication
  • Put technology to work as a tracking tool

Both of these resource will assist your practice in increasing immunization rates by creating an office-wide culture of vaccination.

Adolescent Immunization Resources

The Immunization Action Coalition and Sanofi Pasteur have collaborated a project to raise awareness of the low immunization rates for the meningococcal (MenACWY) vaccination. The project, titled “MenACWY: You’re Not Done if You Give Just One,” can be found at https://www.give2menacwy.org/ and contains a wealth of resources for medical practices.

The facts are stark: Meningococcal disease can be deadly, and survivors can suffer lifelong disabilities from contracting the disease. Unfortunately, the majority of administration opportunities are missed. Even during vaccine only visits, 86% of adolescents were not given MenACWY. 1

The recommended administration guidelines are to give the initial dose at 11-12 years of age and the second dose at 16 years of age. This factsheet provides important information about recommending and administering MenACWY.

Another helpful resource from the MenACWY project is the “Top 10 Ways to Improve Adolescent Immunization Rates” handout. The top 10 are:

  1. Immunize at every opportunity by considering every visit an opportunity to vaccinate.
  2. Use reminder and recall systems to automatically remind families of needed immunizations.
  3. Implement standing orders to allow nurses, pharmacists, and other healthcare personnel to vaccinate.
  4. Take part in an immunization registry to access comprehensive immunization records for every patient.
  5. Review your patients’ vaccination histories prior to visits and flag charts as indicated.
  6. Follow the U.S. recommended immunization schedule.
  7. Schedule vaccination-only quick visits to increase access for patients.
  8. Make vaccination education a priority, for parents as well as patients.
  9. Establish rapport with your adolescent patients by taking a nonjudgmental approach and being ready to listen and answer questions.
  10. Create a culture that values well-adolescent care by maintain the same set of high expectations you take with well-child visits.

Visit the “MenACWY: You’re Not Done if You Give Just One” website at https://www.give2menacwy.org/   for these and other great resources.

In the upcoming months, CPP will continue posting resources on increasing adolescent immunization rates and creating a culture of vaccination in your practice. Subscribe to our blog to stay up to date.

1. Wong CA. Taylor JA, Wright JA, et al. Missed opportunities for adolescent vaccination, 2006–2011. J Adolesc Health. 2013;53(4):492–497.

CDC Webinar – Strategies for Addressing Vaccine Misinformation in the Practice

On Wednesday, August 28, the CDC will be hosting a webinar from 1-2pm to assist providers in recommending vaccines and addressing vaccine hesitancy.

Speakers for the webinar include:

  • Dr. Amanda Cohn, Acting Chief Medical Officer, Vaccine Policy, Preparedness, Global Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
  • Chanie Sternberg, President & CEO, RefuahHealth Center
  • Dr. Corinna Manini, Chief Medical Officer, RefuahHealth Center
  • Dr. Todd Wolynn, CEO, Kids Plus Pediatrics

RefuahHealth is a health center in New York that serves patients in communities affected by ongoing measles outbreaks. They have worked to cultivate trust with parents concerning the safety and efficacy of vaccines.

Follow this link for more information and to register. Don’t wait to register for this timely and relevant information. And stay tuned to the CPP Blog. In the next few months, we will be posting a series on addressing vaccine hesitancy in your practice. Subscribe to our blog to stay up to date!

Group purchasing: Save money by aligning with other physicians

Medical Economics recently published an article highlighting the benefits of partnering with a group purchasing organization (GPO) or physician buying group (PBG). Practices can expect savings ranging from 5 percent to 25 percent by joining such a group. Highlights include:

  • Don’t base your GPO choice on what your hospital uses. Physician offices have different needs than hospitals. Find a group that fits your specific needs.
  • Revisit pricing every year or two and compare groups. The needs of a practice can change over time, and there is no one size fits all solution.
  • Know the difference between a GPO and PBG. GPOs are membership organizations that offer discounts on most everything involved in a medical practice such as capital equipment, supplies, and services. PBGs also offer discounts on supplies and services, but they primarily serve as vaccine buying groups. Due to their vaccine focus, PBGs are able to provide superior pricing.
  • Let your vendors do the work of pricing. Put your top purchased items out for bid to ensure you are getting the best price.
  • Check if your distributor performs additional services like stocking and ordering supplies.

To read more, visit Medical Economics online.

CPP 2nd Dose Grant

This post is the second in a series on increasing adolescent immunizations. For a case study on how one health system increased their overall adolescent vaccination rates, see our previous post.

The CPP 2nd Dose Program provides an opportunity to examine your practice’s 2nd dose immunization rates for vaccines that require more than one dose to complete the series, access resources to help implement a strategy in your office to raise those rates, and share successful strategies with other CPP members. Applicable vaccines include meningococcal ACWY, HPV, adult pneumococcal and/or adult hepatitis B (Heplisav-B only). 

The tables below show immunization rates for these vaccines for the most recent year available from the CDC:

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years—United States, 2017

Vaccine Coverage Among Adults in the United States, National Health Interview Survey, 2016

Participants in CPP’s 2nd Dose Program have already seen successes. Over 77% of member participants reported that their 2nd dose immunization rates were lower than they expected when they pulled the initial data from their EMR. After implementing an intervention in their practice to help improve these rates, participants saw a rise in their HPV and MCV4 completion rates by an average of 29% and 41%, respectively! 

Some best practices that were shared by the group include:

Check out the CPP 2nd Dose Program website for updated resources and details on how your practice can participate in this $1,000 grant opportunity!

How a Large Health System Increased Adolescent Vaccination Rates

This post is the first in a series on adolescent vaccination.

When Sanford Health, a rural not-for-profit health system based in the Dakotas, Minnesota, and Iowa, took a look at their adolescent vaccination rates, they were shocked by what they found. Baseline rates for the completion of the HPV series ranged from 15%-29% in their clinics, and rates for completion of the Meningococcal series ranged from just 8%-38%. Sanford decided to make system-wide changes to improve their adolescent vaccination rates.

Sanford began by creating an immunization strategy department lead by the Immunization Strategy Manager. A cross-department team gathered to form an enterprise immunization committee and craft a plan. The initial stage focused on increasing administration of the HPV vaccine at a test group of seven clinics. The strategy consisted of three parts:

  • Providers were given their immunization rates as well as those of their colleagues. This put accurate data into the providers’ hands and engendered a sense of competition between staff.
  • Sanford emphasized a “no missed vaccination opportunity” culture, encouraging providers to assess immunization status for every patient at every encounter.
  • The system sent reminder and recall letters to parents of adolescents.

Over the two year test period, HPV completion rates increased by an average of 15%, and zero-dose rates decreased an average of 22%. Armed with this data, Sanford made plans to expand the program. The organization added standing orders for most vaccines, enabling RNs, LPNs, and MAs to administer immunizations. These orders eliminated more missed opportunities and empowered staff to own their immunization rates.

Sanford, with the help of the Immunization Action Coalition and Sanofi Pasteur, also created a curriculum to train people to become immunization champions. The VAX Champ program created immunization champions content experts for each clinic. The program also trained its students to examine current vaccination rates and create plans to improve them. These interventions saw first and second dose rates for MenACWY climb steadily. In some clinics, second dose rates more than doubled.

Sanford Health’s efforts helped to not only increase adolescent vaccination rates but also advanced their mission to improve patient health. These steps can be applied to healthcare systems or offices of any size. Sanford’s success shows that with dedication and a solid plan adolescent immunization rates can improve.

Next in this series is a guide to CPP’s 2nd Dose Program that rewards members for improving second dose rates of several immunizations, including those that Sanford highlighted. For more information, visit our website.

Sanofi Pasteur’s Adacel (Tdap) Vaccine FDA Approved for Repeat Vaccination after 8 Years

The Food and Drug Administration recently approved the Adacel (Tdap) vaccine to be administered as soon as 8 years after a previous dose. Adacel, manufactured by Sanofi Pasteur, provides immunity to tetanus, diphtheria, and pertussis. The vaccine is approved for patients ages 10-64, and is available in a syringe made without natural rubber latex.

The current CDC recommendations for Tdap are as follows:

  • Adolescents should receive a single dose, preferably at age 11 or 12
  • All pregnant women should receive a single dose during pregnancy, preferably between weeks 27 and 36. By receiving this vaccine, pregnant mothers pass antibodies to their babies, reducing the risk of whooping cough.
  • Adults should receive a single dose of Tdap followed by a booster Td every 10 years.

FDA approval was based on clinical data from a study that showed no significant differences in adverse events when adults received Adacel versus Td 8-12 years after a previous dose of Adacel.  The approval of Adacel administration every 8 years provides more flexibility for physicians in both vaccine purchasing decisions and immunizations scheduling. Sanofi has provided study results to the CDC for consideration in future recommendations.

For more information or to purchase Adacel or any other immunization, visit our website or send us an email